24
Oct

European regulators have recommended an early approval for AstraZeneca’s new ovarian cancer treatment, welcome news for the company as it defends rosy sales estimates for its oncology pipeline.

…read more

Source: AstraZeneca gets some EU encouragement for its $2B cancer hopeful

    

0 No comments